Skip to main content
Premium Trial:

Request an Annual Quote

Protea, NIOSH Collaborate on Mass Spec-based Toxin Inhalation Research

NEW YORK (GenomeWeb) – Protea Biosciences Group today announced a collaboration with the National Institute for Occupational Safety and Health to use mass spectrometry to study the occupational hazards of inhaling aerosols that are released during welding and electronic manufacturing. 

During the processes, workers are exposed to fumes that may contain harmful chemicals, such as manganese, chromium, and nickel, NIOSH toxicologist James Antonini said, adding that previous research suggests workers who are exposed to such fumes may be at greater risk for lung disease, neurological disorders, and infection. 

"[W]e are working with Protea's Imaging and Bioanalytical Laboratory to understand the molecular interaction and physiological impact of these inhalants," he said in a statement. 

Protea VP of Operations Greg Kilby added, "Developing and applying mass spectrometry imaging workflows for these inhalations studies enables us to deliver molecular images and analytical results, which ultimately have an impact on workplace safety for million of workers in these industries." 

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.